Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of “Buy” by Analysts
Benitec Biopharma Limited (NASDAQ:BNTC – Get Free Report) has been given a consensus rating of “Buy” by the nine analysts that are presently covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month price target […]
Benitec Biopharma Limited (NASDAQ:BNTC – Get Free Report) has been given a consensus rating of “Buy” by the nine analysts that are presently covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month price target […]
